A role for pathogen risk factors and autoimmunity in encephalitis lethargica?

Baltagi, 2010, Neurological sequelae of 2009 influenza A (H1N1) in children: a case series observed during a pandemic, Pediatr. Crit. Care Med., 11, 179, 10.1097/PCC.0b013e3181cf4652 Barletta, 1995, Encephalitis lethargica, Nervenarzt, 66, 781 Basheer, 2007, Anti-basal ganglia antibodies and acute movement disorder following herpes zoster and streptococcal infections, Eur. J. Paediatr. Neurol., 11, 104, 10.1016/j.ejpn.2006.11.001 Blunt, 1997, Clinical features and management of two cases of encephalitis lethargica, Mov. Disord., 12, 354, 10.1002/mds.870120314 Braakman, 2010, Pearls & Oysters: electroconvulsive therapy in anti-NMDA receptor encephalitis, Neurology, 75, e44, 10.1212/WNL.0b013e3181f11dc1 Brenneis, 2007, Encephalitis lethargica following Bartonella henselae infection, J. Neurol., 254, 546, 10.1007/s00415-006-0319-4 Brunetti, 2016, Post-encephalitic Parkinsonism and sleep disorder responsive to immunological treatment: A case report, Clin. EEG Neurosci., 47, 324, 10.1177/1550059416645706 Burr, 2021, N-methyl‑d-aspartate receptor encephalitis associated with COVID-19 infection in a toddler, Pediatr. Neurol., 114, 75, 10.1016/j.pediatrneurol.2020.10.002 Dale, 2012, Autoimmune basal ganglia disorders, J. Child Neurol., 27, 1470, 10.1177/0883073812451327 Dale, 2002, Post-streptococcal autoimmune dystonia with isolated bilateral striatal necrosis, Dev. Med. Child Neurol., 44, 485, 10.1111/j.1469-8749.2002.tb00310.x Dale, 2003, Striatal encephalitis after varicella zoster infection complicated by Tourettism, Mov. Disord., 18, 1554, 10.1002/mds.10610 Dale, 2004, Encephalitis lethargica syndrome: 20 new cases and evidence of basal ganglia autoimmunity, Brain, 127, 21, 10.1093/brain/awh008 Dale, 2007, Contemporary encephalitis lethargica presenting with agitated catatonia, stereotypy, and dystonia-parkinsonism, Mov. Disord., 22, 2281, 10.1002/mds.21664 Dale, 2009, N-methyl-D-aspartate receptor antibodies in pediatric dyskinetic encephalitis lethargica, Ann. Neurol., 66, 704, 10.1002/ana.21807 Dalmau, 2018, Antibody-mediated encephalitis, N. Engl. J. Med., 378, 840, 10.1056/NEJMra1708712 Dalmau, 2008, Anti-NMDA-receptor encephalitis: case series and analysis of the effects of antibodies, Lancet Neurol., 7, 1091, 10.1016/S1474-4422(08)70224-2 Dalmau, 2019, An update on anti-NMDA receptor encephalitis for neurologists and psychiatrists: mechanisms and models, Lancet Neurol., 18, 1045, 10.1016/S1474-4422(19)30244-3 Dauvilliers, 2013, Increased risk of narcolepsy in children and adults after pandemic H1N1 vaccination in France, Brain, 136, 2486, 10.1093/brain/awt187 Dimova, 2006, Acute reversible parkinsonism in Epstein-Barr virus-related encephalitis lethargica-like illness, Mov. Disord., 21, 564, 10.1002/mds.20742 Economo, 1931, Encephalitis lethargica: its sequelae and treatment, Ann Arbor, MI, 1987 Floreani, 2016, Environmental basis of autoimmunity, Clin. Rev. Allergy Immunol., 50, 287, 10.1007/s12016-015-8493-8 Foley, 2015 GRESA-ARRIBAS, 2014, Antibody titres at diagnosis and during follow-up of anti-NMDA receptor encephalitis: a retrospective study, Lancet Neurol, 13, 167, 10.1016/S1474-4422(13)70282-5 Hammer, 2014, Neuropsychiatric disease relevance of circulating anti-NMDA receptor autoantibodies depends on blood-brain barrier integrity, Mol. Psychiatry, 19, 1143, 10.1038/mp.2013.110 Han, 2013, Decreased incidence of childhood narcolepsy 2 years after the 2009 H1N1 winter flu pandemic, Ann. Neurol., 73, 560, 10.1002/ana.23799 Hoffman, 2017, Encephalitis lethargica: 100 years after the epidemic, Brain, 140, 2246, 10.1093/brain/awx177 Howard, 1987, Encephalitis lethargica. A report of four recent cases, Brain, 110, 19, 10.1093/brain/110.1.19 Kayser, 2013, Frequency and characteristics of isolated psychiatric episodes in anti–N-methyl-d-aspartate receptor encephalitis, JAMA Neurol, 70, 1133, 10.1001/jamaneurol.2013.3216 Kiley, 2001, A contemporary case of encephalitis lethargica, Clin. Neuropathol., 20, 2 Kitada, 2011, Dramatic improvement in two cases of anti-NMDA receptor encephalitis after immunomodulating therapy, Rinsho Shinkeigaku, 51, 683, 10.5692/clinicalneurol.51.683 Latorre, 2018, T cells in patients with narcolepsy target self-antigens of hypocretin neurons, Nature, 562, 63, 10.1038/s41586-018-0540-1 Lo, 2003, Lack of detection of influenza genes in archived formalin-fixed, paraffin wax-embedded brain samples of encephalitis lethargica patients from 1916 to 1920, Virchows Arch., 442, 591, 10.1007/s00428-003-0795-1 Lopez-Alberola, 2009, Contemporary encephalitis Lethargica: phenotype, laboratory findings and treatment outcomes, J. Neurol., 256, 396, 10.1007/s00415-009-0074-4 Luo, 2018, Autoimmunity to hypocretin and molecular mimicry to flu in type 1 narcolepsy, Proc. Natl. Acad. Sci. U. S. A., 115, E12323, 10.1073/pnas.1818150116 McCall, 2001, Influenza RNA not detected in archival brain tissues from acute encephalitis lethargica cases or in postencephalitic Parkinson cases, J. Neuropathol. Exp. Neurol., 60, 696, 10.1093/jnen/60.7.696 McCall, 2008, The relationship between encephalitis lethargica and influenza: a critical analysis, J. Neuro-Oncol., 14, 177 Melén, 2020, No evidence of autoimmunity to human OX, J. Transl. Autoimmun., 3, 100055, 10.1016/j.jtauto.2020.100055 Monti, 2020, Anti-NMDA receptor encephalitis presenting as new onset refractory status epilepticus in COVID-19, Seizure, 81, 18, 10.1016/j.seizure.2020.07.006 Nohynek, 2012, AS03 adjuvanted AH1N1 vaccine associated with an abrupt increase in the incidence of childhood narcolepsy in Finland, PLoS One, 7, 10.1371/journal.pone.0033536 Ono, 2007, Steroid-responsive encephalitis lethargica syndrome with malignant catatonia, Intern. Med., 46, 307, 10.2169/internalmedicine.46.6179 Panariello, 2020, Anti-NMDA receptor encephalitis in a psychiatric Covid-19 patient: A case report, Brain Behav. Immun., 87, 179, 10.1016/j.bbi.2020.05.054 Partinen, 2014, Narcolepsy as an autoimmune disease: The role of H1N1 infection and vaccination, Lancet Neurol., 13, 600, 10.1016/S1474-4422(14)70075-4 Paterson, 2020, The emerging spectrum of COVID-19 neurology: clinical, radiological and laboratory findings, Brain, 143, 3104, 10.1093/brain/awaa240 Raghav, 2007, Sporadic encephalitis lethargica, J. Clin. Neurosci., 14, 696, 10.1016/j.jocn.2006.01.016 Ravenholt, 1982, 1918 influenza, encephalitis lethargica, parkinsonism, Lancet, 2, 860, 10.1016/S0140-6736(82)90820-0 Reid, 2001, Experimenting on the past: the enigma of von Economo’s encephalitis lethargica, J. Neuropathol. Exp. Neurol., 60, 663, 10.1093/jnen/60.7.663 Shah, 2011, Two patients with an anti-N-methyl-D-aspartate receptor antibody syndrome-like presentation and negative results of testing for autoantibodies, Pediatr. Neurol., 45, 412, 10.1016/j.pediatrneurol.2011.09.012 Sridam, 2006, Encephalitis lethargica like illness: Case report and literature review, J. Med. Assoc. Thail., 89, 1521 Szakács, 2013, Increased childhood incidence of narcolepsy in western Sweden after H1N1 influenza vaccination, Neurology, 80, 1315, 10.1212/WNL.0b013e31828ab26f Tan, 2010, A modern perspective on the differential diagnosis between encephalitis lethargica or anti-NMDA-receptor encephalitis, J. Clin. Neurosci., 17, 1204, 10.1016/j.jocn.2010.01.010 Titulaer, 2013, Treatment and prognostic factors for long-term outcome in patients with anti-NMDA receptor encephalitis: an observational cohort study, Lancet Neurol., 12, 157, 10.1016/S1474-4422(12)70310-1 Varatharaj, 2020, Neurological and neuropsychiatric complications of COVID-19 in 153 patients: a UK-wide surveillance study, Lancet Psychiatry, 7, 875, 10.1016/S2215-0366(20)30287-X Varga, 2020, Endothelial cell infection and endotheliitis in COVID-19, Lancet, 395, 1417, 10.1016/S0140-6736(20)30937-5 Verschueren, 2001, Bilateral substantia nigra lesions on magnetic resonance imaging in a patient with encephalitis lethargica, J. Neurol. Neurosurg. Psychiatry, 71, 275, 10.1136/jnnp.71.2.275 Vilensky, 2011 Vincent, 2004